NanOX system tested during experimental kidney autotransplantation procedure
This was probably one of the most complex and technologically advanced procedures currently being performed in our country in preclinical and clinical research,” is how
This was probably one of the most complex and technologically advanced procedures currently being performed in our country in preclinical and clinical research,” is how
On July 10, 2024, the company announced that two of its main investors: Michał Lach and Robert Dziubłowski significantly increased their involvement in NanoGroup S.A.
On July 9, 2024, an amendment to the Company’s statute was registered in the National Court Register (KRS). The change in the statute is related
In December 2023, we informed about concluding an advisory agreement with CET Advisors LTD in the commercialization process of projects conducted by NanoSanguis S.A. (hereinafter
We recently informed about the conclusion of an agreement on June 11 between NanoSanguis S.A. with A4BEE. Today we present more information about the cooperation
First we boast about the signed agreement, and soon we hope to boast about the results of our cooperation. We are delighted to have secured
As a result of the subscription of L-series shares and M1-series shares carried out in May, NanoGroup concluded share subscription agreements for a total issue
Once the registration formalities are completed within the stipulated timeframe, the China Patent Office will decide whether to grant the patent right and then a
More than PLN 9 million – this is the total value of the financing that, under the agreement concluded between eCapital sp. z o.o. and
Michal Lach has bet millions on a WSE biotech group that recently came close to insolvency. NanoGroup is also supported by other investors. The entire
Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.
Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.
Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.